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Dermatofibrosarcoma protuberans arising in a decorative tattoo
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Abstract
Dermatofibrosarcoma protuberans (DFSP) is an uncommon, locally aggressive cutaneous tumour of intermediate grade
malignancy. A number of reports have linked local trauma of varying aetiology with the later development of DFSP.
In addition, a variety of skin disorders and, in rare cases, cutaneous tumours, have been described in association with
decorative tattoos. This is often associated with delayed diagnosis. We report the first case of DFSP arising in a tattoo and
discuss the available evidence for a causative link between DFSP and local trauma of this nature.
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Introduction
Dermatofibrosarcoma protuberans (DFSP) is a
rare neoplasm of intermediate grade malignant
potential. It is characterised by latency in its
initial detection, slow infiltrative growth, and
local recurrence if inadequately excised. The
tumour is locally aggressive and rarely metastasises
[1, 12, 13].
A number of authors have reported cases of DFSP
arising at sites of antecedent local trauma of varying
aetiology and have suggested a causal relationship.
Those cases reported to date include the develop-
ment of DFSP at sites of surgical scars, burn scars,
and at sites of prior immunisation and therapeutic
irradiation [2–7, 25–30].
In addition, a wide range of local and systemic
complications have been described in association
with decorative tattooing. These include allergic
reactions, infections and cutaneous disorders such
as psoriasis and seborrhoeic keratosis. More rarely,
however, cutaneous neoplasms such as basal cell
carcinoma, squamous cell carcinoma, and malignant
melanoma have also been described in association
with tattoos [9–11, 32–34].
This is the first report, to our knowledge, of DFSP
occurring in a decorative tattoo.
Case report
A 35-year-old man with no significant past medical
history was referred by his general practitioner to the
local general surgical service for assessment of a
lesion arising in a tattoo. The tattoo was situated on
the dorsum of his left forearm and had been present
for approximately 8 years. Over the past 7 years,
however, the patient had become aware of a slowly
enlarging mass within the pigmented skin. The
patient had previously attended his GP one year
earlier with this problem and had been managed with
reassurance.
On examination, he was found to have a non-
tender, firm mass that was approximately 1cm in
diameter. The mass was mobile and did not appear
to be attached to underlying tissues. There was no
clinical evidence of associated regional lymphade-
nopathy. The lesion was thought to be a simple
epidermoid cyst and local excision was performed
with minimal margins.
The specimen, a ragged fragment of yellow-brown
fibrous tissue (12mm diameter), underwent histo-
logical assessment. This revealed prominent black,
granular pigment within the superficial dermis,
consistent with the history of tattooing at this site
(Figure 1). The epidermis appeared within normal
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DOI: 10.1080/13577140500094289limits. However, a poorly circumscribed tumour was
present within the dermis that infiltrated into the
superficial subcutaneous connective tissue. It was
composed of slender spindle cells arranged focally in
a storiform pattern (Figure 2), the hallmark of DFSP.
These cells had features of intermediate grade
malignancy. The lesion extended to the surgical
margins. Immunohistochemical staining was strongly
positive for vimentin and CD34 (Figure 3), support-
ing the histological diagnosis of DFSP.
As the lesion appeared to be incompletely excised,
the patient was referred to the regional plastic
Figure 1. Black, granular tattoo pigment within superficial dermis. Note underlying spindle cell tumour (haematoxylin & eosin, original
magnification, 4).
Figure 2. Moderately cellular tumour composed of bland, elongated cells with characteristic storiform arrangement (haematoxylin &
eosin, original magnification, 20).
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with a 4-cm margin and the defect covered with a
split skin graft. Pathological examination of this
specimen did not reveal any evidence of residual
disease.
On follow-up, the patient continues to make a
good recovery, with no evidence of recurrent or
metastatic disease at 2 years.
Discussion
Aetiology
There have been several theories on the aetiology of
DFSP [8]; however, the cause of malignant trans-
formation is as yet unknown [12]. There does not
appear to be a hereditary or familial predisposition
and the precise role of recently reported cytogenetic
aberrations has yet to be determined [12].
A number of previous reports have suggested a
causal relationship between antecedent local trauma
of varying aetiology and the subsequent development
of DFSP. These include the development of DFSP
at sites of trauma ranging from ‘vaccination to
bayonet wound’ [2], such as surgical scars [25–27],
burn scars [28,29], sites of prior immunisation [4–7]
and therapeutic irradiation [12,30]. In addition,
increased frequency of trauma to the hands and
feet is thought to account for the higher incidence of
acrally occurring DFSP in children and adolescents
compared to adults [12]. Trauma preceded tumour
development by periods ranging from 2 months to
20 years, although shorter periods tended to pre-
dominate [2]. Furthermore, a clinical history of
previous local trauma was obtained in up to 10–20%
of all cases of DFSP by some authors [2, 8, 12, 26].
It has been suggested that such connective tissue
tumours occur much less frequently than epidermal
malignancies because the deeper tissue is subjected
to less trauma and undergoes less tissue regeneration
than the superficial, more vulnerable, epidermis [28].
It is well known that scars are a predisposing factor
in the development of cutaneous malignancy and
there have been several previous reports of DFSP
occurring in scars of varying aetiology [25–29].
The development of malignancy in vaccination
scars is well recognised and, specifically, several
previous case reports have documented the occur-
rence of DFSP in this setting [2, 4–7]. Local trauma,
wound healing, scarring, infection and also antigenic
stimulation or oncogene transduction by the inocu-
lated infectious agents have been implicated in the
pathogenesis of malignancy in these circumstances
[6]. However, it is impossible to quantify the
potential contribution of each of these factors in
isolation in a single case.
In this case there was a history of focussed local
trauma 1 year prior to the development of this
tumour, which is suggestive of a causal relationship.
Interestingly, some authors have shown that more
rapid growth of the tumour appears to be associated
with an episode of trauma [2]. This unique method
of local trauma is previously undescribed in the
debate on its role in the pathogenesis of this rare
tumour. Tattooing does, however, cause local
trauma in a mode similar to that resulting from
injections and multiple immunisations, a setting
where DFSP has previously been reported [4–7,
28]. It is also possible that persistent inflammation
and wound healing associated with the potentially
toxic inoculated tattoo pigment, as with inoculated
Figure 3. Immunohistochemical staining for vimentin (A) and CD34 (B) is strongly positive, consistent with the diagnosis of DFSP
(original magnifications, 20).
Dermatofibrosarcoma protuberans in a tattoo 39infectious agents, may have contributed to the
subsequent development of DFSP in this case.
Clinical aspects
This case illustrates that DFSP is easily dismissed by
both patient and physician as a benign skin condition
not requiring biopsy. Furthermore, DFSP rarely
presents as a firm cutaneous nodule as in this case
and is infrequently located on the forearm [2]. The
relative paucity of symptoms, non-specific clinical
appearances and indolent behaviour of DFSP often
tends to delay presentation and has led to a variety of
clinical misdiagnoses [8, 12, 20, 26]. In addition, the
presence of tattoo pigments in this case led to a
further delay in the presentation, clinical diagnosis
and treatment. This is a cause for concern and serves
to remind us of previously reported cases of tattoos
masking important diagnoses such as malignant
melanoma [11, 34].
Decorative tattooing has been associated with a
wide range of local and systemic complications.
These include allergic reactions and infections.
Many primary cutaneous disorders such as psoriasis,
lichen planus and discoid lupus erythematosus have
been reported to localise in tattoos [33]. Other
lesions which have been described in association
with tattoos include seborrhoeic keratosis [10] and,
more rarely, cutaneous tumours such as basal cell
carcinoma [9, 35], squamous cell carcinoma [36],
reticulohistiocytoma [9] and malignant melanoma
[11, 34]. This is the first report, to our knowledge, of
DFSP occurring in a decorative tattoo.
Conclusions
A growing body of circumstantial evidence links
DFSP with previous local trauma. However, the
nature and severity of the trauma and the interval
between it and the onset of the tumour varies greatly.
Evidence for a clear causal relationship is lacking due
to limitations imposed by the relative rarity of these
tumours and by the nature of retrospective analysis.
The extent of this association and its underlying
mechanisms therefore remains uncertain. The ques-
tion therefore remains of trauma acting as a trigger in
predisposed individuals or simply attracting attention
to a previously existing mass.
This is the first report of DFSP arising in this
setting. The focus of this article is to report that a
sarcoma such as DFSP has developed at the site of a
tattoo after 1 year. When viewed in this context it
seems reasonable to conclude that the tattoo has had
some contribution to the process of malignant
transformation. In documenting this occurrence we
contribute to the debate and to the body of
circumstantial evidence linking various types of
local trauma to the pathogenesis of this rare
tumour. We speculate that DFSP may have occurred
as a rare delayed complication at the site of a tattoo.
This mode of local trauma is similar to that sustained
at sites of injection and immunisation where the
tumour has previously been described [4–7, 28].
We also add to the list of various cutaneous tumours
documented as occurring at the site of decora-
tive tattooing by contributing a case previously
undescribed. Furthermore, we use this case to
remind doctors to remain vigilant to the possibility
of important diagnoses masked by tattoo pig-
ments and draw attention to the diverse array of
pathologies that have been described and masked in
this setting.
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